奥美拉唑、克拉霉素和阿莫西林三联用药治疗胃炎及十二指肠溃疡的临床疗效  

Clinical efficacy of omeprazole,clarithromycin and amoxicillin in the treatment of gastritis and duodenal ulcer

作　　者：陈娅琦 陈伟[1] Chen Yaqi;Chen Wei(Department of Gastroenterology,Changsha Central Hospital,Hunan Changsha 410000)

机构地区：[1]长沙市中心医院消化内科,湖南长沙410000

出　　处：《中国社区医师》2021年第16期20-21,共2页Chinese Community Doctors

摘　　要：目的:分析奥美拉唑、克拉霉素和阿莫西林治疗胃炎及十二指肠溃疡患者的临床疗效。方法:2019年8月-2020年7月收治胃炎及十二指肠溃疡患者66例,随机分为两组,各33例。试验组采用奥美拉唑、克拉霉素和阿莫西林三联用药治疗;对照组采用奥美拉唑治疗。比较两组治疗效果。结果:试验组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。试验组腹痛消失时间短于对照组,疾病复发率低于对照组,治疗后血清相关指标水平明显优于对照组,差异有统计学意义(P<0.05)。结论:采用奥美拉唑、克拉霉素和阿莫西林三联用药治疗胃炎及十二指肠溃疡,临床疗效显著,可促使患者各项临床症状显著改善。Objective:To analyze the clinical efficacy of omeprazole,clarithromycin and amoxicillin in the treatment of gastritis and duodenal ulcer.Methods:From August 2019 to July 2020,66 patients with gastritis and duodenal ulcer were selected,they were randomly divided into the two groups with 33 cases in each group.The experimental group was treated with omeprazole,clarithromycin and amoxicillin.The control group was treated with omeprazole.The therapeutic effects of the two groups were compared.Results:The total effective rate of the experimental group was higher than that of the control group,the difference was statistically significant(P<0.05).The disappearance time of abdominal pain in the experimental group was shorter than that in the control group,the recurrence rate was lower than that in the control group,and the level of serum related indexes in the experimental group was significantly better than that in the control group after treatment,the difference was statistically significant(P<0.05).Conclusion:The combination of omeprazole,clarithromycin and amoxicillin is effective in the treatment of gastritis and duodenal ulcer,which can significantly improve the clinical symptoms of the patients.

关 键 词：奥美拉唑 克拉霉素 阿莫西林 胃炎 十二指肠溃疡 

分 类 号：R573.1[医药卫生—消化系统] R573.3[医药卫生—内科学]